Latest Central Trust Co (CTTC) Headlines Comp
Post# of 25
Posted On: 03/09/2014 12:46:16 PM
Latest Central Trust Co (CTTC) Headlines
Competitive Tech Names Former "Big Pharma" Sales Executive U.S. Division Head of Product Sales
PR Newswire - Wed Mar 05, 8:14AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names Joel Bradus, former "Big Pharma" sales executive, U.S. division head of product sales. Mr. Bradus was appointed with the full responsibility of steering and expanding the Calmare products sales force in the United States.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company") is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing"), the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500.
Competitive Tech Slated To Present At The See Thru Equity Winter Microcap Investor Conference
PR Newswire - Wed Feb 05, 2:25PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.
WNS (Holdings) Beats Fiscal Q3 Earnings, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 1:10PM CST
WNS (Holdings) reported operating net earnings of 38 cents per share for fiscal third-quarter 2014 ending Dec 31, 2013, beating the Zacks Consensus Estimate.
Competitive Tech's Calmare® Pain Device Therapy Garners Favorable Medicare Coverage Judgment
PR Newswire - Wed Jan 15, 9:35AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a biotechnology company, received a favorable Medicare treatment coverage judgment for its flagship medical technology device, the Calmare® pain therapy medical device, stemming from an appeal filed by an authorized Calmare practitioner in Staten Island, the Physical Medicine and Rehabilitation Associates of Staten Island, LLP (collectively, the Calmare Pain Relief Solutions or CPRS), by and through, Christopher M. Perez, M.D. U.S. Administrative Law Judge LeAnn R. Canter allowed the appeal, which resolved claims for Medicare coverage for a named Medicare enrollee (Beneficiary). The appeal allows CPRS to receive reimbursements for treatments using the Calmare Therapy for claims made in behalf of beneficiary.
WPP Down to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 8:00AM CST
On Jan 2, Zacks Investment Research downgraded WPP to a Zacks Rank #2 (Buy) from a Zacks Rank #1 (Strong Buy).
Furmanite Corp. (FRM) in Focus: Stock Up 7.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:37AM CST
Furmanite Corporation was a big mover last session, as the company saw its shares more than 7% on the day.
WNS (Holdings) Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 1:00PM CST
On Dec 5, Zacks Investment Research upgraded WNS (Holdings) to a Zacks Rank #2 (Buy).
SouFun Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 03, 8:31AM CST
On Dec 2, Soufun touched a 52-week high of $72.65 following the company's announcement that its SouFun Financial Services Channel will be active from Dec 16, 2013.
Competitive Tech Slated To Present At The LD MICRO Microcap Growth Conference
PR Newswire - Wed Nov 27, 8:45AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) a biotechnology company, is slated to present at LD MICRO's 6th Annual Growth Conference on Thursday, December 5, 2013, at 11:30 AM PST / 2:30 PM EST.
In-Line Q3 Loss at Competitive Technologies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 8:10AM CST
Competitive Technologies reported its third-quarter 2013 net loss of 4 cents per share, in line with the Zacks Consensus Estimate. The number also remained unchanged year over year.
Competitive Tech Achieves OTCQX Listing Compliance
PR Newswire - Thu Nov 21, 1:00PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation biotechnology company, was notified yesterday, Wednesday, November 20, 2013 at 2:24 EST that it had returned to good listing compliance with the OTCQX.
Competitive Tech Reports Third Quarter 2013 Results
PR Newswire - Wed Nov 20, 12:21PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation biotechnology company, reported results for three months and nine months ended September 30, 2013.
Calmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy Clinics
Marketwire - Tue Nov 05, 12:20PM CST
Calmare Pain Relief Solutions (the "Company"), a chronic pain treatment medical practice, will increase its Calmare Pain Therapy clinic network by 70% in the Tri-state area in 2014. This expansion is in response to the U.S. Food and Drug Administration's (FDA) position regarding the benefits of using a non-narcotic solution for the relief of chronic pain. This position was highlighted in a recent New York Times article entitled "FDA Shift on Painkillers was Years in the Making."
Competitive Tech Selected To Provide Pain Care Training To U.S. Military Personnel
PR Newswire - Tue Oct 15, 11:54AM CDT
In a pain care skills training for military healthcare providers, technicians, policy makers and program managers in Portsmouth, Virginia, Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) was selected as one of the pain care training providers to our Nation's military personnel. CTI's flagship 510-K cleared and CE-marked medical device, Calmare® was highlighted as a promising pain management device of choice.
Competitive Technologies Announces Financial Results for the Six Months Ended June 30, 2013
GlobeNewswire - Tue Aug 13, 1:14PM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) announced today its financial results for the six months ended June 30, 2013. Revenues for the first half of 2013 were $0.2 million and expenses were $1.7 million producing a net loss for the first half of 2013 of $1.5 million.
Forest Rehabilitation Medicine PC Opens Sixth Clinic Utilizing Calmare/Scrambler Chronic Pain Therapy on Staten Island and Brooklyn
Marketwire - Thu Jun 27, 7:33AM CDT
Forest Rehabilitation Medicine PC a chronic pain treatment medical practice with multiple locations on Staten Island and now in Brooklyn, announced today the opening of its sixth clinic at the offices of Daniel W. Wilen, MD, Board-certified Orthopedic Surgeon, at 9202 Fort Hamilton Parkway, Brooklyn, New York 11209, using Calmare/Scrambler Therapy, a non-invasive and non-narcotic therapy for the treatment of chronic neuropathic pain.
Competitive Technologies, Inc. Announces Sales of Its Calmare(R) Pain Therapy Medical Device
GlobeNewswire - Tue Jun 25, 9:43AM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) today announced two recent sales of Calmare medical devices, one to a military hospital and one to a physician practice, both located in the Northwest region of the United States.
Competitive Technologies Shareholders Elected Directors at Annual Shareholder Meeting
GlobeNewswire - Thu Jun 20, 10:44AM CDT
Competitive Technologies Inc. (OTCQX:CTTC) held its annual meeting of shareholders earlier today at the Norwalk Inn and Conference Center in Norwalk, Conn. CTTC's Chairman, Peter Brennan conducted the business meeting and President and Chief Executive Officer, Carl O'Connell, provided an overview of the Company's plans.
Competitive Tech Names Former "Big Pharma" Sales Executive U.S. Division Head of Product Sales
PR Newswire - Wed Mar 05, 8:14AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), names Joel Bradus, former "Big Pharma" sales executive, U.S. division head of product sales. Mr. Bradus was appointed with the full responsibility of steering and expanding the Calmare products sales force in the United States.
Pipeline Mosque Inaugurates Africell-Sponsored Minaret
All Africa Global Media - Tue Feb 25, 11:05AM CST
The Pipeline Mosque on Friday inaugurated its new 33.35 meters minaret, reportedly sponsored by Africell GSM Company to the tune of D1 million.
Noka Resources Closes Oversubscribed Second Tranche of Financing
Marketwire - Tue Feb 25, 8:05AM CST
Noka Resources Inc. (TSX VENTURE: NX)(FRANKFURT: 2NK) (the "Company") is pleased to announce that, further to the Company's news release dated February 6, 2014 whereas the Company closed $597,500 of the Non-Brokered Private Placement financing (the "Financing"), the Company has closed the second tranche of the Financing for additional gross proceeds of $536,000, bringing the total amount raised to $1,133,500.
Competitive Tech Slated To Present At The See Thru Equity Winter Microcap Investor Conference
PR Newswire - Wed Feb 05, 2:25PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), the pain mitigation company, is slated to present at the SeeThruEquity Winter Microcap Investor Conference on Thursday, February 6, 2014, at 1:30 PM EST.
WNS (Holdings) Beats Fiscal Q3 Earnings, Revs Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Jan 16, 1:10PM CST
WNS (Holdings) reported operating net earnings of 38 cents per share for fiscal third-quarter 2014 ending Dec 31, 2013, beating the Zacks Consensus Estimate.
Competitive Tech's Calmare® Pain Device Therapy Garners Favorable Medicare Coverage Judgment
PR Newswire - Wed Jan 15, 9:35AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a biotechnology company, received a favorable Medicare treatment coverage judgment for its flagship medical technology device, the Calmare® pain therapy medical device, stemming from an appeal filed by an authorized Calmare practitioner in Staten Island, the Physical Medicine and Rehabilitation Associates of Staten Island, LLP (collectively, the Calmare Pain Relief Solutions or CPRS), by and through, Christopher M. Perez, M.D. U.S. Administrative Law Judge LeAnn R. Canter allowed the appeal, which resolved claims for Medicare coverage for a named Medicare enrollee (Beneficiary). The appeal allows CPRS to receive reimbursements for treatments using the Calmare Therapy for claims made in behalf of beneficiary.
WPP Down to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 8:00AM CST
On Jan 2, Zacks Investment Research downgraded WPP to a Zacks Rank #2 (Buy) from a Zacks Rank #1 (Strong Buy).
Furmanite Corp. (FRM) in Focus: Stock Up 7.2% in Session - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Jan 03, 7:37AM CST
Furmanite Corporation was a big mover last session, as the company saw its shares more than 7% on the day.
WNS (Holdings) Upped to Buy - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Dec 05, 1:00PM CST
On Dec 5, Zacks Investment Research upgraded WNS (Holdings) to a Zacks Rank #2 (Buy).
SouFun Shares Hit 52-Week High - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Dec 03, 8:31AM CST
On Dec 2, Soufun touched a 52-week high of $72.65 following the company's announcement that its SouFun Financial Services Channel will be active from Dec 16, 2013.
Competitive Tech Slated To Present At The LD MICRO Microcap Growth Conference
PR Newswire - Wed Nov 27, 8:45AM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) a biotechnology company, is slated to present at LD MICRO's 6th Annual Growth Conference on Thursday, December 5, 2013, at 11:30 AM PST / 2:30 PM EST.
In-Line Q3 Loss at Competitive Technologies - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Nov 22, 8:10AM CST
Competitive Technologies reported its third-quarter 2013 net loss of 4 cents per share, in line with the Zacks Consensus Estimate. The number also remained unchanged year over year.
Competitive Tech Achieves OTCQX Listing Compliance
PR Newswire - Thu Nov 21, 1:00PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation biotechnology company, was notified yesterday, Wednesday, November 20, 2013 at 2:24 EST that it had returned to good listing compliance with the OTCQX.
Competitive Tech Reports Third Quarter 2013 Results
PR Newswire - Wed Nov 20, 12:21PM CST
Competitive Technologies, Inc., (OTCQX: CTTC) (CTI), a pain mitigation biotechnology company, reported results for three months and nine months ended September 30, 2013.
Calmare Pain Relief Solutions Adds New Calmare(R) Pain Therapy Clinics
Marketwire - Tue Nov 05, 12:20PM CST
Calmare Pain Relief Solutions (the "Company"), a chronic pain treatment medical practice, will increase its Calmare Pain Therapy clinic network by 70% in the Tri-state area in 2014. This expansion is in response to the U.S. Food and Drug Administration's (FDA) position regarding the benefits of using a non-narcotic solution for the relief of chronic pain. This position was highlighted in a recent New York Times article entitled "FDA Shift on Painkillers was Years in the Making."
Competitive Tech Selected To Provide Pain Care Training To U.S. Military Personnel
PR Newswire - Tue Oct 15, 11:54AM CDT
In a pain care skills training for military healthcare providers, technicians, policy makers and program managers in Portsmouth, Virginia, Competitive Technologies, Inc., (OTCQX: CTTC) (CTI) was selected as one of the pain care training providers to our Nation's military personnel. CTI's flagship 510-K cleared and CE-marked medical device, Calmare® was highlighted as a promising pain management device of choice.
Competitive Technologies Announces Financial Results for the Six Months Ended June 30, 2013
GlobeNewswire - Tue Aug 13, 1:14PM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) announced today its financial results for the six months ended June 30, 2013. Revenues for the first half of 2013 were $0.2 million and expenses were $1.7 million producing a net loss for the first half of 2013 of $1.5 million.
Forest Rehabilitation Medicine PC Opens Sixth Clinic Utilizing Calmare/Scrambler Chronic Pain Therapy on Staten Island and Brooklyn
Marketwire - Thu Jun 27, 7:33AM CDT
Forest Rehabilitation Medicine PC a chronic pain treatment medical practice with multiple locations on Staten Island and now in Brooklyn, announced today the opening of its sixth clinic at the offices of Daniel W. Wilen, MD, Board-certified Orthopedic Surgeon, at 9202 Fort Hamilton Parkway, Brooklyn, New York 11209, using Calmare/Scrambler Therapy, a non-invasive and non-narcotic therapy for the treatment of chronic neuropathic pain.
Competitive Technologies, Inc. Announces Sales of Its Calmare(R) Pain Therapy Medical Device
GlobeNewswire - Tue Jun 25, 9:43AM CDT
Competitive Technologies, Inc. (OTCQX:CTTC) today announced two recent sales of Calmare medical devices, one to a military hospital and one to a physician practice, both located in the Northwest region of the United States.
Competitive Technologies Shareholders Elected Directors at Annual Shareholder Meeting
GlobeNewswire - Thu Jun 20, 10:44AM CDT
Competitive Technologies Inc. (OTCQX:CTTC) held its annual meeting of shareholders earlier today at the Norwalk Inn and Conference Center in Norwalk, Conn. CTTC's Chairman, Peter Brennan conducted the business meeting and President and Chief Executive Officer, Carl O'Connell, provided an overview of the Company's plans.
(0)
(0)Calmare Therapeutics, Inc (CTTC) Stock Research Links
Scroll down for more posts ▼